Prospective studies of troponin (cTnI) assays in acute coronary syndromes have demonstrated that cTnI have diagnostic accuracy better than CK-MB [1-3], ECGs [3] and can better predict long-term risk for adverse cardiac events [4-6]. This evidence concerns the gene TNNI3 and acute coronary syndrome.